
VIP Study
@vipstudy1
SARS-CoV2 Vaccination immunogenicity
in Immunosuppressed inflammatory bowel disease Patients.
ID: 1400405062250287106
03-06-2021 10:53:02
57 Tweet
150 Followers
50 Following




Crohn's & Colitis UK The IBS Network Bowel Research UK @BladderAndBowel @VOICE__Global Community Voices NWL



James Alexander Metabolism, Digestion & Reproduction presenting the work from him and NickPowellLab from the VIP Study, assessing impact of immune responses to #COVID19 vaccines in immunosuppressed #IBD patients - out now in full in The Lancet Gastroenterology & Hepatology: thelancet.com/journals/langa…



…and James is hard at work again! Now presenting his work in NickPowellLab Metabolism, Digestion & Reproduction the influence of the gut #microbiome and #metabolome upon immune responses to #COVID19 vaccines in #IBD patients… preprint online here: doi.org/10.21203/rs.3.… NationalPhenomeC(UK)




VIP Study NickPowellLab Tariq Ahmad In this edition of The Lancet Gastroenterology & Hepatology #jamesalexander

The latest The Lancet Gastroenterology & Hepatology podcast is now online—I had the pleasure of speaking to James Alexander of Metabolism, Digestion & Reproduction about the latest VIP Study data on #COVID19 vaccine responses in patients with #IBD Listen: buzzsprout.com/1728646/114428… Paper: thelancet.com/journals/langa…


The last of the late breakers is presented by James Alexander Metabolism, Digestion & Reproduction, with data from VIP Study looking at COVID-19 vaccine-induced antibody & T-cell responses in immunosuppressed patients with inflammatory bowel disease after the 3rd vaccine dose #UEGWeek #gitwitter #IBD

Great to see Dr James Alexander Metabolism, Digestion & Reproduction Imperial Hepatology presenting the latest results from the VIP Study at my_UEG #UEGWeek, exploring immune responses after 3rd dose of #COVID19 vaccination in #IBD patients - paper on this now out in The Lancet Gastroenterology & Hepatology: thelancet.com/journals/langa…



👀More data from VIP Study Main message for #IBDpatients - ✔️ get NEW boosters = protection against Omicron variants. New boosters especially ☑️☑️ for those on anti -TNF and tofacitinib drugs. #COVID19Ab #IBD Gastroenterology NickPowellLab

👀More data from VIP Study Main message for #IBDpatients - ✔️ get NEW boosters = protection against Omicron variants. New boosters especially ☑️☑️ for those on anti -TNF and tofacitinib drugs. #COVID19Ab #IBD Gastroenterology NickPowellLab gastrojournal.org/article/S0016-…

What's the relationship between mood and physical health, when it comes to Crohn's and Colitis? The mindbodyibdstudy is investigating that very question, and they're offering £15 worth of vouchers to those taking part. Find out more 👇 crohnsandcolitis.org.uk/get-involved/w…

